21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT
Regains Compliance with NYSE American Continued Listing Standards
Announces Q2 2026 Results and Provides Business Updates
Announces Breakthrough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
Other Events
Authorized Share Increase Approved at Azitra, Inc. Annual Meeting
Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
Announces Q1 2026 Results and Provides Business Updates
Q2
Q1
FY 2025
Q3
FY 2023
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload